Barclays
CLVT icon

Barclays’s Clarivate CLVT Stock Holding History

Barclays’s Portfolio CLVT Stock Details CLVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393K Sell
181,723
-40,027
-18% -$97.9K ﹤0.01% 3349
2026
Q1 		$561K Sell
221,750
-82,357
-27% -$211K ﹤0.01% 3129
2025
Q4 		$1.02M Buy
304,107
+159,335
+110% +$566K ﹤0.01% 3417
2025
Q3 		$554K Sell
144,772
-33,222
-19% -$140K ﹤0.01% 3741
2025
Q2 		$765K Buy
177,994
+59,863
+51% +$241K ﹤0.01% 3512
2025
Q1 		$464K Buy
118,131
+26,716
+29% +$127K ﹤0.01% 3572
2024
Q4 		$464K Sell
91,415
-28,803
-24% -$166K ﹤0.01% 3867
2024
Q3 		$854K Sell
120,218
-102,591
-46% -$654K ﹤0.01% 3467
2024
Q2 		$1.27M Sell
222,809
-27,084
-11% -$173K ﹤0.01% 2457
2024
Q1 		$1.86M Buy
249,893
+29,337
+13% +$245K ﹤0.01% 2635
2023
Q4 		$2.04M Sell
220,556
-934,030
-81% -$6.9M ﹤0.01% 2905
2023
Q3 		$7.75M Buy
1,154,586
+862,936
+296% +$6.88M ﹤0.01% 1107
2023
Q2 		$2.78M Buy
291,650
+20,999
+8% +$178K ﹤0.01% 1676
2023
Q1 		$2.54M Sell
270,651
-12,931
-5% -$133K ﹤0.01% 2017
2022
Q4 		$2.37M Sell
283,582
-46,889
-14% -$440K ﹤0.01% 2147
2022
Q3 		$3.1M Buy
330,471
+119,507
+57% +$1.51M ﹤0.01% 1451
2022
Q2 		$2.92M Sell
210,964
-148,328
-41% -$2.22M ﹤0.01% 1616
2022
Q1 		$6.02M Buy
359,292
+117,094
+48% +$1.94M ﹤0.01% 1139
2021
Q4 		$5.7M Sell
242,198
-37,348
-13% -$865K ﹤0.01% 1613
2021
Q3 		$6.12M Sell
279,546
-28,482
-9% -$693K ﹤0.01% 1492
2021
Q2 		$8.48M Buy
308,028
+272,453
+766% +$7.49M ﹤0.01% 1275
2021
Q1 		$938K Buy
35,575
+34,370
+2,852% +$940K ﹤0.01% 2820
2020
Q4 		$36K Sell
1,205
-2,051
-63% -$60.6K ﹤0.01% 4541
2020
Q3 		$100K Sell
3,256
-544
-14% -$14.7K ﹤0.01% 4250
2020
Q2 		$85K Buy
3,800
+2,202
+138% +$49.7K ﹤0.01% 4618
2020
Q1 		$33K Sell
1,598
-38,146
-96% -$764K ﹤0.01% 5447
2019
Q4 		$668K Buy
39,744
+38,070
+2,274% +$641K ﹤0.01% 4041
2019
Q3 		$28K Buy
+1,674
New +$27.7K ﹤0.01% 6127

Other funds holding CLVT

LGP
Leonard Green & Partners Los Angeles, California $962M AUM 35.11% 1-Year Est. Return
ENV
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.18B AUM 0.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Barclays's CLVT Position: Q2 2026 in Review

Barclays reduced its Clarivate (CLVT) stake by 18% in Q2 2026, selling an estimated $97.9K and leaving 181,723 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #3349.

Barclays first reported a position in CLVT in Q3 2019 and has held it in 28 quarters since. The position peaked at $8.48M in Q2 2021. 242 funds tracked by Wall St. Rank hold CLVT as of Q2 2026.

  • Barclays held 181,723 shares of Clarivate worth $393K as of Q2 2026.
  • Barclays sold 40,027 Clarivate shares in Q2 2026, an estimated $97.9K.
  • Clarivate made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3349 holding.
  • Barclays first reported a position in Clarivate in Q3 2019 and has held it in 28 quarters since.
  • Barclays's Clarivate position peaked at $8.48M in Q2 2021.
  • 242 funds tracked by Wall St. Rank held Clarivate as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.